Your Shopping Cart Is Empty
| Report Code: A03231 | Jul 2021 | Pages: 290 | ||
| Tables: 133 | Charts: 48 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cell Expansion Market
Request Now !The global cell expansion market was valued at $13,066.2 million in 2020, and is projected to reach $39,031.1 million by 2030, registering a CAGR of 11.6% from 2021 to 2030.
The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global cell expansion market. The COVID-19 pandemic has helped the industry grow significantly, as the demand for cell expansion products such as consumables including sera, media, and reagent and instrument increased.
Cell expansion is the process of producing daughter cells from a single cell. Cell expansion requires the synthesis of new cell wall material and controlled loosening of the wall to allow it to stretch and increase in area. Cell-wall-associated proteins of the so-called expansion family are key components in this process. It is utilized in drug development, drug screening, and cell microbiology research. Cell expansion is now frequently utilized to improve transplantation and the treatment of diseases, including rheumatoid arthritis and diabetes.
The growth in incidences of chronic diseases such as diabetes, rheumatoid arthritis, and cancer is key factor that drives the growth of the global cell expansion market. In addition, rise in government investments for cell-based research and increase in focus on R&D for cell-based therapies further drive the growth of the market. However, ethical concerns regarding research in cell biology, shortage of skilled professionals, and high cost of cell-based therapies may hamper the growth of the cell expansion market. On the contrary, growth in opportunity in emerging markets and rise in focus on personalized medicine create lucrative opportunities for the cell expansion market.
The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. However, there has also been a positive effect and surge in demand for various medical services, including cell expansion. Cell-based approaches, primarily using mesenchymal stromal cells (MSCs), offers a promising approach toward mitigating the adverse effects of the COVID-19 infection. This therapy has shown to reduce the expression of pro-inflammatory cytokines as well as repair of damaged tissues in COVID-19 patients. According to the WHO ICTRP and the NIH ClinicalTrials.gov databases, 27 clinical investigations of MSC-based cell therapy approaches have begun in China since the onset of the COVID-19 outbreak, as well as a growing number of academic and industry trials elsewhere. Regenerative medicine & stem cell research is one of the major applications of cell expansion. This is a major indicator of market growth as stem cell-based therapies are showing significant potential in COVID-19 study. In addition, various cell expansion products (such as cell culture media) and instruments (such as bioreactors) are being used in COVID-19 research. Hence, the outbreak of COVID-19 has positively impacted the cell expansion market.
The global cell expansion market is segmented on the basis of product, application, end user, and region. By product, the market is bifurcated into instruments and consumables. By application, the market is divided into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. Others again classified into clinical studies and toxicology studies. By end user, it is classified into research institutes, pharmaceutical & biotechnology companies, and others. Others is again segmented into CROs, forensic, and diagnostic laboratories. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product, the market is segmented into consumable and instrument. The consumables segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in production of vaccines and other biologics in the biopharmaceutical and biotechnology industries.
Based on application, the market is segmented into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. The tissue engineering & regenerative medicine segment is expected to be the second largest during the forecast period, owing to recent advancements in regenerative medicine and tissue engineering and increased funding for regenerative medicine.
Based on end user, the market is divided into research institutes, pharmaceutical & biotechnology companies, and others. Pharmaceutical & biotechnology companies held the largest market share in 2020, and is expected to remain dominant throughout the forecast period, owing to broadening horizon of cell-based therapeutics in the healthcare industry, high burden of chronic diseases, and increase in R&D activities in the pharmaceutical and biotechnology industries.
Asia-Pacific is expected to exhibit the fastest market growth during the forecast period, owing to constantly expanding healthcare infrastructure and economic development. In addition, Asia-Pacific offers profitable opportunities for key players operating in the cell expansion market; thereby, registering the fastest growth rate during the forecast period, mainly due to economic development and low operating costs.
The major driving factors for the market growth in this region include rise in focus in biopharmaceutical R&D, huge production of drugs, and surge in prevalence of cancer. In addition, increasing efforts laid down by several local pharmaceutical and biotechnology companies to develop and commercialize their cellular therapies further boost the market growth. For instance, an Indian company, Stempeutics Research Pvt. Ltd., signed an alliance with Kemwell Biopharma in July 2019 for the commercialization of its stem cell-based product, Stempeucel. Such agreements are expected to boost the product sales of small- and mid-scale companies.
The key market players profiled in the report include Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.
Key Benefits For Stakeholders
Key Market Segments
By Product
By Application
By End User
By Region
Cell Expansion Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT |
|
| By APPLICATION |
|
| By END USER |
|
| By Region |
|
| Key Market Players | DANAHER CORPORATION, PromoCell GmbH, Lonza Group Ltd, HIMEDIA LABORATORIES, Becton, Dickinson, and Company, Merck KGAA, EPPENDORF CORPORATE, CORNING GROUP, INC., THERMO FISHER SCIENTIFIC, INC., SARTORIUS AG |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of chronic diseases
3.5.1.2.Surge in government investments for cell-based research
3.5.1.3.Rise in focus on R&D for cell-based therapies
3.5.2.Restraints
3.5.2.1.High cost of cell-based therapies
3.5.2.2.Dearth of skilled professionals
3.5.2.3.Ethical concerns regarding research in cell biology
3.5.3.Opportunities
3.5.3.1.Growth in opportunities in emerging markets
3.5.3.2.Rise in focus on personalized medicine
3.5.4.Impact analysis
3.6.COVID-19 impact analysis on the cell expansion market
CHAPTER 4:CELL EXPANSION MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Instruments
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:CELL EXPANSION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Stem cell technology
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Cancer research
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Drug screening & development
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
5.5.Tissue engineering & regenerative medicine
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.5.3.Market analysis, by country
5.6.Others
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast
5.6.3.Market analysis, by country
CHAPTER 6:CELL EXPANSION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Research institutes
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by type
6.2.4.Consumables
6.2.4.1.Market size and forecast
6.2.5.Instruments
6.2.5.1.Market size and forecast
6.3.Pharmaceutical & biotechnology companies
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by type
6.3.4.Consumables
6.3.4.1.Market size and forecast
6.3.5.Instruments
6.3.5.1.Market size and forecast
6.4.Others
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
6.4.3.Market size and forecast, by type
6.4.4.Consumables
6.4.4.1.Market size and forecast
6.4.5.Instruments
6.4.5.1.Market size and forecast
CHAPTER 7:CELL EXPANSION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. cell expansion market, by product
7.2.2.1.2.U.S. Cell expansion market, by application
7.2.2.1.3.U.S. Cell expansion market, by end user
7.2.2.2.Canada
7.2.2.2.1.Canada Cell expansion market, by product
7.2.2.2.2.Canada Cell expansion market, by application
7.2.2.2.3.Canada Cell expansion market, by end user
7.2.2.3.Mexico
7.2.2.3.1.Mexico Cell expansion market, by product
7.2.2.3.2.Mexico Cell expansion market, by application
7.2.2.3.3.Mexico Cell expansion market, by end user
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user
7.2.5.1.North America research institutes market, by product
7.2.5.2.North America pharmaceutical & biotechnology companies market, by product
7.2.5.3.North America others market, by product
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany Cell expansion market, by product
7.3.2.1.2.Germany Cell expansion market, by application
7.3.2.1.3.Germany Cell expansion market, by end user
7.3.2.2.France
7.3.2.2.1.France Cell expansion market, by product
7.3.2.2.2.France Cell expansion market, by application
7.3.2.2.3.France Cell expansion market, by end user
7.3.2.3.UK
7.3.2.3.1.UK Cell expansion market, by product
7.3.2.3.2.UK Cell expansion market, by application
7.3.2.3.3.UK Cell expansion market, by end user
7.3.2.4.Italy
7.3.2.4.1.Italy Cell expansion market, by product
7.3.2.4.2.Italy Cell expansion market, by application
7.3.2.4.3.Italy Cell expansion market, by end user
7.3.2.5.Spain
7.3.2.5.1.Spain Cell expansion market, by product
7.3.2.5.2.Spain Cell expansion market, by application
7.3.2.5.3.Spain Cell expansion market, by end user
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe Cell expansion market, by product
7.3.2.6.2.Rest of Europe Cell expansion market, by application
7.3.2.6.3.Rest of Europe Cell expansion market, by end user
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.3.5.1.Europe research institutes market, by product
7.3.5.2.Europe pharmaceutical & biotechnology companies market, by product
7.3.5.3.Europe others market, by product
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan Cell expansion market, by product
7.4.2.1.2.Japan Cell expansion market, by application
7.4.2.1.3.Japan Cell expansion market, by end user
7.4.2.2.China
7.4.2.2.1.China Cell expansion market, by product
7.4.2.2.2.China Cell expansion market, by application
7.4.2.2.3.China Cell expansion market, by end user
7.4.2.3.Australia
7.4.2.3.1.Australia Cell expansion market, by product
7.4.2.3.2.Australia Cell expansion market, by application
7.4.2.3.3.Australia Cell expansion market, by end user
7.4.2.4.India
7.4.2.4.1.India Cell expansion market, by product
7.4.2.4.2.India Cell expansion market, by application
7.4.2.4.3.India Cell expansion market, by end user
7.4.2.5.South Korea
7.4.2.5.1.South Korea Cell expansion market, by product
7.4.2.5.2.South Korea Cell expansion market, by application
7.4.2.5.3.South Korea Cell expansion market, by end user
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific Cell expansion market, by product
7.4.2.6.2.Rest of Asia-Pacific Cell expansion market, by application
7.4.2.6.3.Rest of Asia-Pacific Cell expansion market, by end user
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.5.1.Asia-Pacific Research Institutes market, by product
7.4.5.2.Asia-Pacific pharmaceutical & biotechnology companies market, by product
7.4.5.3.Asia-Pacific others market, by product
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil Cell expansion market, by product
7.5.2.1.2.Brazil Cell expansion market, by application
7.5.2.1.3.Brazil Cell expansion market, by end user
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia Cell expansion market, by product
7.5.2.2.2.Saudi Arabia Cell expansion market, by application
7.5.2.2.3.Saudi Arabia Cell expansion market, by end user
7.5.2.3.South Africa
7.5.2.3.1.South Africa Cell expansion market, by product
7.5.2.3.2.South Africa Cell expansion market, by application
7.5.2.3.3.South Africa Cell expansion market, by end user
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA Cell expansion market, by product
7.5.2.4.2.Rest of LAMEA Cell expansion market, by application
7.5.2.4.3.Rest of LAMEA Cell expansion market, by end user
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
7.5.5.1.LAMEA Research Institutes market, by product
7.5.5.2.LAMEA pharmaceutical & biotechnology companies market, by product
7.5.5.3.LAMEA others market, by product
CHAPTER 8:COMPANY PROFILES
8.1.Becton, Dickinson, and Company
8.1.1.Company overview
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Business performance
8.2.CORNING GROUP, INC.
8.2.1.Company overview
8.2.2.Operating business segments
8.2.3.Product portfolio
8.2.4.Business performance
8.2.5.Key strategic moves and developments
8.3.DANAHER CORPORATION
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.EPPENDORF CORPORATE
8.4.1.Company overview
8.4.2.Operating business segments
8.4.3.Product portfolio
8.4.4.Business performance
8.4.5.Key strategic moves and developments
8.5.HIMEDIA LABORATORIES
8.5.1.Company overview
8.5.2.Operating business segments
8.5.3.Product portfolio
8.5.4.Key strategic moves and developments
8.6.Lonza Group Ltd
8.6.1.Company overview
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Business performance
8.6.5.Key strategic moves and developments
8.7.Merck KGAA
8.7.1.Company overview
8.7.2.Operating business segments
8.7.3.Product portfolio
8.7.4.Business performance
8.8.PromoCell GmbH
8.8.1.Company overview
8.8.2.Operating business segments
8.8.3.Product portfolio
8.9.SARTORIUS AG
8.9.1.Company overview
8.9.2.Operating business segments
8.9.3.Product portfolio
8.9.4.Business performance
8.9.5.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Operating business segments
8.10.3.Product portfolio
8.10.4.Business performance
8.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL CELL EXPANSION MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 02.CONSUMABLES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 03.INSTRUMENTS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 04.GLOBAL CELL EXPANSION MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 05.STEM CELL TECHNOLOGY CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 06.CANCER RESEARCH CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 07.DRUG SCREENING AND DEVELOPMENT CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 08.TISSUE ENGINEERING & REGENERATIVE MEDICINE CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 09.OTHERS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10.CELL EXPANSION MARKET, BY END USER, 2020-2030($MILLION)
TABLE 11.RESEARCH INSTITUTES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 12.CELL EXPANSION MARKET, FOR RESEARCH INSTITUTE, BY TYPE, 2020–2030, ($MILLION)
TABLE 13.PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 14.CELL EXPANSION MARKET, FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY TYPE, 2020–2030, ($MILLION)
TABLE 15.OTHERS CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 16.CELL EXPANSION MARKET, FOR OTHERS, BY TYPE, 2020–2030, ($MILLION)
TABLE 17.CELL EXPANSION MARKET, BY REGION, 2020-2030($MILLION)
TABLE 18.NORTH AMERICA CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 19.U.S. CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 20.U.S. CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 21.U.S. CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 22.CANADA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 23.CANADA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 24.CANADA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 25.MEXICO CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 26.MEXICO CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 27.MEXICO CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 28.NORTH AMERICA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 29.NORTH AMERICA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 30.NORTH AMERICA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 31.NORTH AMERICA RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
TABLE 32.NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
TABLE 33.NORTH AMERICA OTHERS MARKET, BY PRODUCT, 2020-2030
TABLE 34.EUROPE CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 35.GERMANY CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 36.GERMANY CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 37.GERMANY CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 38.FRANCE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 39.FRANCE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 40.FRANCE CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 41.UK CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 42.UK CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 43.UK CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 44.ITALY CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 45.ITALY CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 46.ITALY CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 47.SPAIN CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 48.SPAIN CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 49.SPAIN CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 50.REST OF EUROPE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 51.REST OF EUROPE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 52.REST OF EUROPE CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 53.EUROPE CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 54.EUROPE CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 55.EUROPE CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 56.EUROPE RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
TABLE 57.EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
TABLE 58.EUROPE OTHERS MARKET, BY PRODUCT, 2020-2030
TABLE 59.ASIA-PACIFIC CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 60.JAPAN CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 61.JAPAN CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 62.JAPAN CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 63.CHINA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 64.CHINA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 65.CHINA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 66.AUSTRALIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 67.AUSTRALIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 68.AUSTRALIA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 69.INDIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 70.INDIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 71.INDIA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 72.SOUTH KOREA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 73.SOUTH KOREA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 74.SOUTH KOREA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 75.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 76.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 77.REST OF ASIA-PACIFIC CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 78.ASIA-PACIFIC CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 79.ASIA-PACIFIC CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 80.ASIA-PACIFIC CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 81.ASIA-PACIFIC RESEARCH INSTITUTES MARKET, BY PRODUCT, 2020-2030
TABLE 82.ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY PRODUCT, 2020-2030
TABLE 83.ASIA-PACIFIC OTHERS MARKET, BY PRODUCT, 2020-2030
TABLE 84.LAMEA CELL EXPANSION MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 85.BRAZIL CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 86.BRAZIL CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 87.BRAZIL CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 88.SAUDI ARABIA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 89.SAUDI ARABIA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 90.SAUDI ARABIA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 91.SOUTH AFRICA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 92.SOUTH AFRICA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 93.SOUTH AFRICA CELL EXPANSION MARKET, BY END USER 2020-2030
TABLE 94.REST OF LAMEA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 95.REST OF LAMEA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 96.REST OF LAMEA CELL EXPANSION MARKET, END USER, 2020-2030
TABLE 97.LAMEA CELL EXPANSION MARKET, BY PRODUCT, 2020-2030
TABLE 98.LAMEA CELL EXPANSION MARKET, BY APPLICATION, 2020-2030
TABLE 99.LAMEA CELL EXPANSION MARKET, BY END USER, 2020-2030
TABLE 100.LAMEA RESEARCH INSTITUTES, BY PRODUCT, 2020-2030
TABLE 101.LAMEA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY PRODUCT, 2020-2030
TABLE 102.LAMEA OTHERS MARKET, BY PRODUCT, 2020-2030
TABLE 103.BD: COMPANY SNAPSHOT
TABLE 104.BD: OPERATING SEGMENTS
TABLE 105.BD: PRODUCT PORTFOLIO
TABLE 106.CORNING: COMPANY SNAPSHOT
TABLE 107.CORNING: OPERATING SEGMENTS
TABLE 108.CORNING: PRODUCT PORTFOLIO
TABLE 109.DANAHER: SNAPSHOT
TABLE 110.DANAHER: OPERATING SEGMENTS
TABLE 111.DANAHER: PRODUCT PORTFOLIO
TABLE 112.EPPENDORF: COMPANY SNAPSHOT
TABLE 113.EPPENDORF: OPERATING SEGMENTS
TABLE 114.EPPENDORF: PRODUCT PORTFOLIO
TABLE 115.HIMEDIA: COMPANY SNAPSHOT
TABLE 116.HIMEDIA: OPERATING SEGMENTS
TABLE 117.HIMEDIA: PRODUCT PORTFOLIO
TABLE 118.LONZA: COMPANY SNAPSHOT
TABLE 119.LONZA: OPERATING SEGMENTS:
TABLE 120.LONZA: PRODUCT PORTFOLIO
TABLE 121.MERCK: COMPANY SNAPSHOT
TABLE 122.MERCK: OPERATING SEGMENTS
TABLE 123.MERCK: PRODUCT PORTFOLIO
TABLE 124.PROMOCELL: COMPANY SNAPSHOT
TABLE 125.PROMOCELL: OPERATING SEGMENTS
TABLE 126.PROMOCELL: PRODUCT PORTFOLIO
TABLE 127.SARTORIUS: COMPANY SNAPSHOT
TABLE 128.SARTORIUS: OPERATING SEGMENTS
TABLE 129.SARTORIUS: PRODUCT PORTFOLIO
TABLE 130.SARTORIUS: KEY DEVELOPMENTS
TABLE 131.THERMO FISCHER: COMPANY SNAPSHOT
TABLE 132.THERMO FISCHER: OPERATING SEGMENTS
TABLE 133.THERMO FISCHER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL CELL EXPANSION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.MODERATE THREAT OF SUBSTITUTES
FIGURE 04.LOW THREAT OF NEW ENTRANTS
FIGURE 05.HIGH INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF CONSUMABLES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 09.COMPARATIVE ANALYSIS OF INSTRUMENTS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 10.COMPARATIVE ANALYSIS OF STEM CELL TECHNOLOGY CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF CANCER RESEARCH CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF DRUG SCREENING AND DEVELOPMENT CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF TISSUE ENGINEERING & REGENERATIVE MEDICINE CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF OTHERS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF RESEARCH INSTITUTES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.CONSUMABLES CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 17.INSTRUMENTS CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.CONSUMABLES CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 20.INSTRUMENTS CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF OTHERS CELL EXPANSION MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.CONSUMABLES CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 23.INSTRUMENTS CELL EXPANSION MARKET, 2020–2030, ($MILLION)
FIGURE 24.CANCER INCIDENCES IN GERMANY (2007 & 2050)
FIGURE 25.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.BD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.CORNING: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.CORNING: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.EPPENDORF: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.EPPENDORF: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.EPPENDORF: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.LONZA: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.LONZA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.LONZA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 41.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.SARTORIUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.NET SALES, 2018–2020 ($MILLION)
FIGURE 47.THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48.THERMO FISCHER: REVENUE SHARE BY REGION, 2020 (%)
Cell expansion is the large-scale artificial generation of daughter cells from a single cell. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies.
Increase in prevalence of chronic diseases, surge in government support and investment for cell-based therapies, and rise in focus on R&D for cell-based therapies are expected to drive the growth of the cell expansion market. Furthermore, growing opportunities in emerging economies and increase in focus on personalized medicine also create a lucrative opportunity for the market growth. However, high cost of cell-based research and their treatment and shortage of skilled professionals and ethical concerns regarding research in cell biology are expected to hinder the growth of the market.
The consumable segment is expected to remain dominant during the forecast period, owing to increase in production of vaccines and other biologics in the biopharmaceutical and biotechnology industries. Moreover, North America is expected to offer lucrative opportunities to the key players during the forecast period, due to rise in incidences of cancer, increase in government funding, rise in research activates on stem cell therapies, and growth in awareness regarding advanced treatment methods.
A. Cell expansion is the large-scale artificial generation of daughter cells from a single cell.
A. The total market value of Cell Expansion market is $13,066.20 million in 2020.
A. The market value of Cell Expansion market in 2021 is $14,542.68 million.
A. The base year is 2020 in Cell Expansion market
A. Top companies such as Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories held a high market position in 2020.
A. Consumable segment is the most influencing segment owing to owing to the increasing production of vaccines and other biologics in the biopharmaceutical and biotechnology industries.
A. Increase in government support and investment for cell-based therapies, growing focus on R&D for cell-based therapies, are expected to drive the growth of the cell expansion market. Furthermore, growing opportunities in emerging economies and increase in focus on personalized medicine also create a lucrative opportunity for market growth.
A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to owing to constantly expanding healthcare infrastructure, economic development, and low operating costs.
A. The forcast period for Cell Expansion market is 2021 to 2030
A. The process of cell expansion is being used for several applications, which includes microlevel research of cells, screening of drugs, therapeutic development, and among others.
Start reading instantly.
This Report and over 68,439+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report